PubRank

Mark G Erlander

Author PubWeight™ 47.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling. Proc Natl Acad Sci U S A 2007 8.23
2 A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 2004 8.06
3 Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A 2003 6.35
4 Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population. Lancet Oncol 2013 2.53
5 The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer. J Clin Oncol 2006 2.24
6 Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J Clin Invest 2004 1.82
7 Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitors. Cancer Res 2009 1.54
8 Breast cancer index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early- and late-distant recurrence. Clin Cancer Res 2013 1.31
9 Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker. J Natl Cancer Inst 2013 1.19
10 Nuclei and subnuclei gene expression profiling in mammalian brain. Brain Res 2002 1.15
11 Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction. Oncologist 2010 1.14
12 Laser capture microdissection and advanced molecular analysis of human breast cancer. J Mammary Gland Biol Neoplasia 2003 1.01
13 A retrospective study of treatment outcomes in patients with carcinoma of unknown primary site and a colorectal cancer molecular profile. Clin Colorectal Cancer 2011 0.98
14 BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease. Oncotarget 2014 0.96
15 Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance. Clin Cancer Res 2008 0.95
16 Development and validation of a 32-gene prognostic index for prostate cancer progression. Proc Natl Acad Sci U S A 2013 0.95
17 Molecular classification of unknown primary cancer. Semin Oncol 2009 0.93
18 Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer. Breast Cancer Res 2011 0.92
19 Blinded comparator study of immunohistochemical analysis versus a 92-gene cancer classifier in the diagnosis of the primary site in metastatic tumors. J Mol Diagn 2012 0.88
20 Multisite validation study to determine performance characteristics of a 92-gene molecular cancer classifier. Clin Cancer Res 2012 0.87
21 HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease. Breast Cancer Res 2013 0.86
22 Molecular classification of cancers of unknown primary site. Mol Diagn Ther 2009 0.86
23 Laser capture microdissection and its applications in genomics and proteomics. Methods Enzymol 2002 0.84
24 Global gene expression analysis of single cells. Curr Opin Drug Discov Devel 2003 0.83
25 Gene expression-based diagnostics for molecular cancer classification of difficult to diagnose tumors. Expert Opin Med Diagn 2012 0.79
26 RE: A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 2004 0.75
27 Cost effectiveness of a 92-gene assay for the diagnosis of metastatic cancer. J Med Econ 2014 0.75
28 Health economic analysis of Breast Cancer Index in patients with ER+, LN- breast cancer. Am J Manag Care 2014 0.75